Stefan Zastrow

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Klaus‐Peter Dieckmann, Arlo Radtke, Lajos Géczi et al. · Journal of Clinical Oncology · 2019 · 343 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Vaccination of hormone‐refractory prostate cancer patients with peptide cocktail‐loaded dendritic cells: Results of a phase I clinical trial

Susanne Fuessel, Axel Meye, Marc Schmitz et al. · The Prostate · 2006 · 125 citations

Medicine, Immunology, Oncology +17

Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma

Oliver W. Hakenberg, Johannes Nippgen, Michael Froehner et al. · British Journal of Urology · 2006 · 114 citations

Medicine, Oncology, Pharmacology +14

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear‐cell renal cell carcinoma revealed by genome‐wide expression analyses of primary tumors and metastases

Daniela Wuttig, Stefan Zastrow, S. Füssel et al. · International Journal of Cancer · 2011 · 113 citations

Medicine, Cancer Biology, Oncology +17

Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)

Sabine Brookman‐May, Matthias May, Shahrokh F. Shariat et al. · European Urology · 2012 · 105 citations · Full text

Medicine, Oncology, Surgery +17